IL6 and congenital rubella syndrome: Similarly to what was observed in patients and in previous preclinical studies (14, 19, 32, 41), CRS development in mice was associated with elevation of serum IL-6 and SAA, which were both higher in mice treated with CAR TBULK compared with mice that received CAR TN/SCM (Figure 4, E and F).